CHM and breast carcinoma: The top two hits were from studies on diffuse large B cell lymphoma [40] (GEO accession GSE10846) and breast cancer [41] (GEO accession GSE24450), and both showed that poor survival was significantly associated with low expression of CHM (Fig 4E and 4D, respectively).